Back
Can Fite Biofarma Vs. Disc Medicine Industry Stock Comparison
Sell
42
CANF
Can Fite Biofarma
Last Price:
2.02
Seasonality Move:
0.68%
Buy
75
IRON
Disc Medicine
Last Price:
50.16
Seasonality Move:
1.34%
Sell
42
Can Fite Biofarma (CANF)
is a Sell
Is Can Fite Biofarma a Buy, Sell or Hold?
- The current Can Fite Biofarma [CANF] share price is $2.02. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Disc Medicine (IRON)
is a Buy
Is Disc Medicine a Buy, Sell or Hold?
- The current Disc Medicine [IRON] share price is $50.07. The Score for IRON is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- IRON is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CANF Stock Price Chart
What is Can Fite Biofarma's stock price today?
-
The Can Fite Biofarma share price today is $2.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight buying pressure.
IRON Stock Price Chart
What is Disc Medicine's stock price today?
-
The Disc Medicine share price today is $50.07
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IRON is experiencing buying pressure, which is a positive indicator for future bullish movement.
CANF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 36.28 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.08 - 2.36) | Sell |
| Bollinger Bands (100): | (2.11 - 3.15) | Sell |
IRON Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 59.46 | Buy |
| Chaikin Money Flow: | 114716 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.7 - 50.08) | Buy |
| Bollinger Bands (100): | (37.1 - 49.34) | Buy |
CANF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.04 | Sell |
| 20-day SMA: | 2.2 | Sell |
| 50-day SMA: | 2.59 | Sell |
| 200-day SMA: | 2.36 | Sell |
| 8-day EMA: | 2.07 | Sell |
| 20-day EMA: | 2.19 | Sell |
| 50-day EMA: | 2.41 | Sell |
| 200-day EMA: | 2.56 | Sell |
IRON Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.08 | Buy |
| 20-day SMA: | 48.77 | Buy |
| 50-day SMA: | 47.02 | Buy |
| 200-day SMA: | 49.06 | Buy |
| 8-day EMA: | 48.36 | Buy |
| 20-day EMA: | 48.3 | Buy |
| 50-day EMA: | 47.13 | Buy |
| 200-day EMA: | 46.05 | Buy |
Can Fite Biofarma Earnings Growth & CANF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.04 per share.
Disc Medicine Earnings Growth & IRON Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.20 per share, a decrease this year of $1.28 per share, and a decrease next year of $0.51 per share.
Can Fite Biofarma Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Disc Medicine Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||